Company profile
AccurKardia
ECG-led Diagnostics
- Industry
- Software Development
- Employees
- 20
- Headquarters
- New York, NY
- Founded
- 2019
- LinkedIn followers
- 2,878
- Office locations
- 2
AccurKardia company summary
AccurKardia is a company in the Software Development industry, headquartered in New York, NY, founded in 2019. On LinkedIn the company has around 20 employees and 2,878 followers. The company lists 2 office locations. Its listed specialties include artificial intelligence, AI, cardiac healthcare, ecg analysis, healthtech.
What technology does AccurKardia use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About AccurKardia
AccurKardia is an ECG-led diagnostics software company transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives globally. Its cloud-based platform includes AccurECG™, an FDA-cleared Class II software as a medical device (SaMD) that delivers fully automated, near real-time ECG interpretation and integrates seamlessly into existing clinical workflows. AccurECG™ was named “Best New ECG Technology” at the 2025 MedTech Breakthrough Awards. AccurKardia’s pipeline includes AK+ Guard™—an AI-driven hyperkalemia detection solution using Lead I ECG data to help identify life-threatening high potassium levels earlier in patients with CKD and ESRD—which received FDA Breakthrough Device Designation and acceptance into FDA’s Total Product Life Cycle (TAP) program in December 2024; and AK-AVS™, an AI model for aortic stenosis detection via 12-lead ECGs, which received FDA Breakthrough Device Designation in October 2024. AccurKardia completed the 2024 MedTech Innovator (MTI) cohort and was one of five companies selected for the American Heart Association’s inaugural Heart & Brain Health Accelerator track within MTI. AccurKardia also completed Cohort 3 of Mayo Clinic Platform_Accelerate in 2023. (AK+ Guard™ and AK-AVS™ are investigational and not commercially available.)
Specialties
Where is AccurKardia located?
AccurKardia lists 2 office locations.
Compare companies similar to AccurKardia
More companies in Software Development.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
AccurKardia accurkardia.com | Software Development | 20 | 2019 | New York, NY |
 Vagas.com vagas.com.br | Software Development | 3,304 | 1999 | São Paulo, SP |
 Salesforce Work.com salesforce.com | Software Development | 87,907 | - | San Francisco, California |
 Microsoft github.com | Software Development | 6,587 | 2008 | San Francisco, CA |
 SAP Concur sap.com | Software Development | 147,691 | 1972 | Walldorf, BW |
 Upwork upwork.com | Software Development | 176,790 | 2015 | San Francisco, California, US |
 TechCrunch techcrunch.com | Software Development | 582 | - | San Francisco, California |
 Zoho zoho.com | Software Development | 30,854 | - | Chennai, Tamil Nadu |
 Canva canva.com | Software Development | 17,794 | 2012 | Surry Hills, New South Wales, AU |
 Atlassian atlassian.com | Software Development | 21,061 | 2002 | Sydney, NSW, AU |
 Shopee shopee.com | Software Development | 76,519 | - | Singapore, Singapore, SG |
Frequently asked questions about AccurKardia
What does AccurKardia do?
AccurKardia is an ECG-led diagnostics software company transforming ECG data into a more powerful diagnostic tool and broad biomarker to improve patient outcomes and save lives globally. Its cloud-based platform includes AccurECG™, an FDA-cleared Class II software as a medical device (SaMD) that delivers fully automated, near real-time ECG interpretation and integrates seamlessly into existing clinical workflows. AccurECG™ was named “Best New ECG Technology” at the 2025 MedTech Breakthrough Awards. AccurKardia’s pipeline includes AK+ Guard™—an AI-driven hyperkalemia detection solution using Lead I ECG data to help identify life-threatening high potassium levels earlier in patients with CKD and ESRD—which received FDA Breakthrough Device Designation and acceptance into FDA’s Total Product Life Cycle (TAP) program in December 2024; and AK-AVS™, an AI model for aortic stenosis detection via 12-lead ECGs, which received FDA Breakthrough Device Designation in October 2024. AccurKardia completed the 2024 MedTech Innovator (MTI) cohort and was one of five companies selected for the American Heart Association’s inaugural Heart & Brain Health Accelerator track within MTI. AccurKardia also completed Cohort 3 of Mayo Clinic Platform_Accelerate in 2023. (AK+ Guard™ and AK-AVS™ are investigational and not commercially available.)
How many employees does AccurKardia have?
AccurKardia has around 20 employees on LinkedIn.
Where is AccurKardia headquartered?
AccurKardia is headquartered in New York, NY.
Where does AccurKardia have offices?
AccurKardia lists 2 office locations, including New York, NY, US.
When was AccurKardia founded?
AccurKardia was founded in 2019.
Build a lead list from companies like AccurKardia
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.